US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 2.0050
  • +0.0250+1.26%
Trading Feb 26 10:46 ET
72.38MMarket Cap-0.45P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 25.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 25.000K--
Nov 14, 20242024/Q30.000 / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

  • Inovio Pharmaceuticals | 8-K: INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 14, 2024 16:11 ET

  • Inovio Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 16:09 ET

  • Inovio Pharmaceuticals | 8-K: INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 8, 2024 17:06 ET

  • Inovio Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:14 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    WANDA BEARING
    920002
    +30.00%
    CG MED EQUIP.
    838810
    +29.94%
    SUZHOUBEARING
    430418
    +22.35%
    4
    COCYBER
    835207
    +21.31%
    5
    Guangdong Create Century Intelligent Equipment Group Corporation
    300083
    +20.05%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Monetary Policy: Navigating the Fed's Rate Cut Cycle
    Changing Fed policy is altering the market math for investors.
    Discussing
    Tesla's earnings caused fluctuations, what's your market outlook？
    Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
    TSLA earnings preview: Grab rewards by guessing the opening price!